The 20 Best Urothelial Cancer Doctors Near Me in Charleston, SC

Dr. Stephen Savage graduated from Dartmouth College in 1989, completed medical school at the Columbia University College of Physicians and Surgeons in 1993 and received his urology training at the Mount Sinai Medical Center in New York City in 1999. He went on to receive fellowship training in minimally invasive urology at the Cleveland Clinic Foundation. Following completion of his fellowship, he was the director of minimally invasive urology at Mount Sinai Medical Center from 2000 through 2002 when he joined the staff at Memorial Sloan Kettering Cancer Center to help develop their minimally invasive urologic oncology program. He joined the staff at the Medical University of South Carolina and Hollings Cancer Center in 2004 as an associate professor of urology and director of minimally invasive urology.Dr. Savage has interest and expertise in the minimally invasive treatment of urologic cancers including prostate, kidney, bladder and testicular. He has performed complex minimally invasive surgeries since 1999 and continues to utilize these techniques to benefit patients in the approach to urologic cancer. He has published numerous articles related to urologic cancers and participates in many multidisciplinary clinical trials. He is the vice chairman of the Department of Urology and is the director of the urologic oncology fellowship at MUSC. Dr. Savage is rated as a Distinguished provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Ureterocele, Nephrectomy, and Reconstructive Urology Surgery.

Dr. Theodore S. Gourdin is a board-certified oncologist specializing in genitourinary cancer. He has a particular interest in treating urothelial cancer of the bladder.His medical degree was awarded by the University of South Carolina School of Medicine. He completed his residency in internal medicine at Tulane University School of Medicine and his fellowship in hematology/oncology at the University of Maryland Marlene and Stewart Greenebaum Cancer Center. ,Dr. Gourdin is accepting patients at the MUSC Hollings Cancer Center in downtown Charleston. Dr. Gourdin is rated as a Distinguished provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Prostate Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, and Bladder Cancer.

Dr. Thai Ho has been caring for patients affected by genitourinary cancers for over 10 years. His area of expertise and the focus of his research is in treating kidney and bladder cancers. He also sees patients with kidney, bladder, upper tract urothelial, and prostate cancers, as well as patients affected by hereditary cancer syndromes. Dr. Ho completed the Baylor College of Medicine Physician Scientist Program in 2006, internal medicine residency at Washington University in St. Louis in 2009, and Medical Oncology Fellowship at MD Anderson Cancer Center in 2012.Dr. Ho's research is funded by the National Institutes of Health and Department of Defense to better match cancer patients with targeted therapies by using precision medicine approaches to identify a cancer's unique vulnerabilities. At MUSC Hollings Cancer Center, Dr. Ho is the Director of Precision Medicine and an Associate Professor in the Division of Hematology \& Oncology. Prior to joining MUSC, Dr. Ho was an Associate Professor faculty the Mayo Clinic where he was a member of the Center for Individualized Medicine Epigenomics Group, Genomic Tumor Board, and von Hippel-Lindau Clinic. Dr. Ho is rated as a Distinguished provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Renal Cell Carcinoma (RCC), Clear Cell Sarcoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Orchiectomy.

Thomas Keane is an Oncologist in Charleston, South Carolina. Dr. Keane is rated as a Distinguished provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Prostate Cancer, Bladder Cancer, Muscle Invasive Bladder Cancer, Reconstructive Urology Surgery, and Nephrectomy.

Harry Clarke is an Oncologist in Charleston, South Carolina. Dr. Clarke is rated as a Distinguished provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Reconstructive Urology Surgery, and Nephrectomy.

Tracy Tipton is a Urologist in Mount Pleasant, South Carolina. Dr. Tipton is rated as a Distinguished provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Enlarged Prostate (BPH), Ureteroscopy, and Prostatectomy.

Dr. John B. Adams, II, is a board-certified urologist who treats adults ages 18 and above. A native of Savannah, Georgia, Dr. Adams earned his medical degree from Emory University School of Medicine in Atlanta, Georgia. Upon graduation, he completed a urological residency at Emory University Hospital, followed by a laparoscopy and minimally invasive surgery fellowship at the prestigious Johns Hopkins Hospital. After serving as a full-time faculty member at the Medical College of Georgia in Augusta, Dr. Adams returned to the Lowcountry, bringing his world-class medical training. He is dedicated to attaining the highest levels of medical education and providing the latest advances in urological care. Dr. Adams is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Perirenal Abscess, Ureteroscopy, and Prostatectomy.

Dr. Matvey Tsivian is a board-certified, fellowship-trained urologic oncologist. Dr. Tsivian graduated Magna cum Laude from the University of Bologna Medical School in Italy, followed by an internship and residency at Duke University Medical Center. He then completed a urologic oncology fellowship at Mayo Clinic in Rochester, Minnesota. Prior to joining MUSC Health in 2024, Dr. Tsivian was an Assistant Professor of Urology at Atrium Health Wake Forest Baptist Comprehensive Cancer Center.Dr. Tsivian is quadrilingual, with a fluency in English, Hebrew, Russian, and Italian. He has [published numerous articles](https://pubmed.ncbi.nlm.nih.gov/?term=Tsivian+M&cauthor_id=24101216) related to urologic cancers and participates in many genitourinary oncology clinical trials. Dr. Tsivian is the Director of the Urologic Oncology Fellowship at the Medical University of South Carolina. Dr. Tsivian is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Bladder Cancer, Renal Cell Carcinoma (RCC), Urothelial Cancer, Nephrectomy, and Prostatectomy.

Dr. Daniel Landau is a board certified Hematologist/Oncologist. He has been in practice since 2011. Dr. Landau obtained his medical degree and residency from the University of South Florida College of Medicine and then completed his hematology/oncology fellowship at the Orlando Health Cancer Institute (previously a part of MD Anderson). Dr. Landau's has been at the forefront of managing both benign and malignant conditions. He has also served in a number of roles beyond being a clinician including the institution of a telehealth service within Orlando Health. He now joins MUSC in a telehealth role. Dr. Landau has also provided a major role in medical education, having trained physicians for more than a decade. Dr. Landau has been published/ presented research within the New England Journal of Medicine, American Society of Clinical Oncology and American society of Hematology. Dr. Landau is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Clear Cell Sarcoma, WT1-Related Wilms Tumor Syndromes, Familial Prostate Cancer, Multiple Myeloma, and Bone Marrow Aspiration.

Nicholas Shaheen, MD, specializes in Radiology. Dr. Shaheen is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Bladder Cancer, Urothelial Cancer, and Small Bowel Resection.

Dr. Kevin Becker is a medical oncologist who cares for patients with genitourinary cancers, including prostate, kidney and bladder. Dr. Becker received his medical degree from Columbia University College of Physicians and Surgeons in 2004. He completed an Internal Medicine residency and a Hematology and Oncology fellowship at New York Presbyterian/Columbia University Medical Center. In 2020, he received a Master of Medical Management degree from Carnegie Mellon University. He completed the Northwell Health Physician Leadership Development Program in 2021. Dr. Becker's research aims to expand and improve treatment options through cancer treatment clinical trials.Before joining MUSC, Dr. Becker was the Medical Director of the Maimonides Cancer Center in Brooklyn, New York, and Chief of the Regional Division of Hematology and Oncology for Maimonides and Downstate Health Sciences University. Dr. Becker is the Director of Oncology Infusion and Ambulatory Services at MUSC Hollings Cancer Center. Dr. Becker is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Clear Cell Sarcoma, and Chromophobe Renal Cell Carcinoma.

Dr. Ricardo Yamada graduated in medicine from Universidade Federal do Rio de Janeiro, Brazil, in 2004 and completed his residency in diagnostic radiology in 2009 in the same institution. He moved to the United States in 2011, where he had three years of extensive training in interventional radiology, including three fellowships: vascular and interventional radiology, body imaging and interventional radiology, and pediatric interventional radiology. He is interested in areas such as peripheral arterial disease, vascular anomalies, and oncology, including pediatric interventions. Dr. Yamada is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Fibrolamellar Carcinoma, Familial Pancreatic Cancer, End-Stage Renal Disease (ESRD), Liver Embolization, and Bone Marrow Aspiration.

Eric S. Rovner, M.D. is the director of the section of voiding dysfunction, female urology, and urodynamics in the Department of Urology at MUSC. He has a highly specialized clinical practice within urology and sees mostly patients with complex voiding problems including urinary incontinence, vaginal prolapse, urinary fistulae, and neurogenic bladder dysfunction. Dr. Rovner is a board-certified member of the American Urological Association, fellow of the American College of Surgeons, as well as a member of the American Association of GU Surgeons, Society of Pelvic Surgeons, Society of University Urologists, Societe Internationale D'Urologie, and the Society for Urodynamics, Female Urology, and Urogenital Reconstruction (SUFU), among others. Dr. Rovner has served on several committees for the WHO international consultation on incontinence, and served as a member of the American Urological Association's stress incontinence surgery guidelines committee. He is a past president of SUFU, past chair of the young urologists committee of the AUA and past member of the AUA education council as well as the ABU/AUA written and oral examination committees. Dr. Rovner's research interests include the study of voiding dysfunction, incontinence, overactive bladder, neurourology, and urodynamics. He has held several visiting professorships nationally and internationally, and is the author of over 150 peer-reviewed scientific articles, monographs, and book chapters on these topics as well as a book on urinary incontinence and urodynamics. He has been an invited speaker on numerous occasions throughout the United States and the world and has been the principal or co-investigator on multiple grants. Dr. Rovner is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Urinary Incontinence, Stress Urinary Incontinence, Frequent or Urgent Urination, Reconstructive Urology Surgery, and Bladder Reconstruction.

Kevin Smith is an Interventional Radiologist in Charleston, South Carolina. Dr. Smith is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Visceromegaly, Ascites, Pleurisy, Bone Graft, and Vertebroplasty.

Christopher Hannegan is an Interventional Radiologist in Charleston, South Carolina. Dr. Hannegan is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are End-Stage Renal Disease (ESRD), Muscle Invasive Bladder Cancer, Urothelial Cancer, Liver Embolization, and Bone Marrow Aspiration.

Dennis Kubinski is a Urologist in Mount Pleasant, South Carolina. Dr. Kubinski is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Retroperitoneal Fibrosis, Reconstructive Urology Surgery, and Nephrectomy.

John Britton is a Urologist in Charleston, South Carolina. Dr. Britton is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Kidney Stones, Boils, Prostate Cancer, Reconstructive Urology Surgery, and Nephrectomy.

Bradley Steele is a Urologist in Charleston, South Carolina. Dr. Steele is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Urinary Tract Infection in Children, Boils, Kidney Stones, Ureteroscopy, and Reconstructive Urology Surgery.

Jonathan Donaldson is a Urologist in Mount Pleasant, South Carolina. Dr. Donaldson is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Urinary Tract Infection in Children, Urinary Incontinence, Urinary Tract Infection (UTI), Prostatectomy, and Ureteroscopy.

Stanley Hall is a Urologist in Mount Pleasant, South Carolina. Dr. Hall is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Urinary Tract Infection in Children, Obstructive Uropathy, Carbuncle, Ureteroscopy, and Prostatectomy.